CAS 50309-53-0

4-[2-(dimethylamino)ethyl]benzene-1,2-diol hydrobromide

Description:

4-[2-(Dimethylamino)ethyl]benzene-1,2-diol hydrobromide, with the CAS number 50309-53-0, is a chemical compound characterized by its structure, which includes a benzene ring substituted with two hydroxyl groups and a dimethylaminoethyl side chain. This compound typically appears as a hydrobromide salt, which enhances its solubility in water and other polar solvents. The presence of the dimethylamino group suggests potential basicity, allowing it to participate in various chemical reactions, including protonation and nucleophilic substitutions. The hydroxyl groups contribute to its polarity and can engage in hydrogen bonding, influencing its reactivity and interactions with biological systems. This compound may exhibit pharmacological properties, making it of interest in medicinal chemistry, particularly in the development of therapeutic agents. Its hydrobromide form indicates that it can be used in various formulations, potentially affecting its stability and bioavailability. Overall, the characteristics of this compound make it a subject of interest in both synthetic and applied chemistry contexts.

Formula: C₁₀H₁₆BrNO₂

Synonyms:

• Dopamine Impurity 42 HBr
• Dopamine Impurity 42
• 4-[2-(dimethylamino)ethyl]benzene-1,2-diol hydrobromide

Dopamine Impurity 42 HBr

CAS: 50309-53-0

Formula: C₁₀H₁₅NO₂·HBr

Molecular weight: 181.24 80.91

Ref: 4Z-D-3291

4-[2-(Dimethylamino)ethyl]benzene-1,2-diol Hydrobromide

Controlled Product

CAS: 50309-53-0

Formula: C₁₀H₁₅NO₂·HBr

Color and Shape: Neat

Molecular weight: 262.144

Ref: TR-B403075

4-[2-(Dimethylamino)ethyl]benzene-1,2-diol hydrobromide

CAS: 50309-53-0

4-[2-(Dimethylamino)ethyl]benzene-1,2-diol hydrobromide (DMAB) is a potent and selective inhibitor of cocaine-induced chronotropic and pressor responses in rats. DMAB also inhibits the release of dopamine from rat brain nerve endings. In addition, it has been shown to inhibit the binding of cocaine to ganglionic nerve endings and bulbocapnine receptors. The drug appears to be well tolerated following oral administration in animals, as no changes in blood pressure or heart rate were observed.

Formula: C₁₀H₁₆BrNO₂

Purity: Min. 95%

Molecular weight: 262.14 g/mol

Ref: 3D-ACA30953